美国 · SEC FORM 4
Schrodinger, Inc.
SDGR · Nasdaq · CIK 0001490978 · Healthcare · Health Information Services
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
3 sales · 11 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-02-05 · Lebowitz Joel.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 10,131,631
- 上期报告
- 11,169,335
- 日均成交量
- 3,300,490
- 回补天数
- 3.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2021-02-05 | Lebowitz Joel | 买入 (P) | Common Stock | 1,115 | USD 99.90 | USD 111,388 | SEC 申报 ↗ |
| 2020-02-10 | BILL & MELINDA GATES FOUNDATION TRUST | 买入 (P) | Common stock | 588,235 | USD 17.00 | USD 9,999,995 | SEC 申报 ↗ |
| 2020-02-10 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | 买入 (P) | Common Stock | 250,000 | USD 17.00 | USD 4,250,000 | SEC 申报 ↗ |
Form 4 申报证据
50 transaction lines in the latest 365-day window; 918 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Akinsanya Karen | 卖出 (S) | Common Stock | 31,599 | USD 29.37 | USD 927,970 | SEC 申报 ↗ |
| 2026-09-17 | Akinsanya Karen | 期权行权／转换 (M) | Common Stock | 31,599 | USD 4.34 | USD 137,140 | SEC 申报 ↗ |
| 2026-07-16 | Jain Rachit | 卖出 (S) | Common Stock | 875 | USD 15.60 | USD 13,650 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Akinsanya Karen | 卖出 (S) | Common Stock | 31,599 | USD 29.37 | USD 927,970 | SEC 申报 ↗ |
| 2026-09-17 | Akinsanya Karen | 期权行权／转换 (M) | Common Stock | 31,599 | USD 4.34 | USD 137,140 | SEC 申报 ↗ |
| 2026-07-16 | Jain Rachit | 卖出 (S) | Common Stock | 875 | USD 15.60 | USD 13,650 | SEC 申报 ↗ |
| 2026-06-26 | Friesner Richard | 赠与 (G) | Common Stock | 679,373 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | van Kralingen Bridget A | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Thornberry Nancy | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Sender Gary | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | OBEROI ARUN | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Lynton Michael | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Kapeller-Libermann Rosana | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | GINSBERG GARY L | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Friesner Richard | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-22 | Chodakewitz Jeffrey | 奖励／授予 (A) | Common Stock | 8,141 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-17 | Farid Ramy | 卖出 (S) | Common Stock | 43,000 | USD 12.21 | USD 525,030 | SEC 申报 ↗ |
| 2026-04-17 | Farid Ramy | 期权行权／转换 (M) | Common Stock | 117,527 | USD 3.07 | USD 360,808 | SEC 申报 ↗ |
| 2026-04-16 | Jain Rachit | 卖出 (S) | Common Stock | 844 | USD 12.75 | USD 10,761 | SEC 申报 ↗ |
| 2026-04-16 | Farid Ramy | 卖出 (S) | Common Stock | 43,000 | USD 12.33 | USD 530,190 | SEC 申报 ↗ |
| 2026-04-16 | Farid Ramy | 期权行权／转换 (M) | Common Stock | 43,000 | USD 3.07 | USD 132,010 | SEC 申报 ↗ |
| 2026-03-06 | Herman Jenny | 卖出 (S) | Common Stock | 608 | USD 12.84 | USD 7,807 | SEC 申报 ↗ |
| 2026-03-05 | Tran Yvonne | 卖出 (S) | Common Stock | 1,094 | USD 12.90 | USD 14,113 | SEC 申报 ↗ |
| 2026-03-05 | Lorton Kenneth Patrick | 卖出 (S) | Common Stock | 1,222 | USD 12.90 | USD 15,764 | SEC 申报 ↗ |
| 2026-03-05 | Jain Rachit | 卖出 (S) | Common Stock | 1,631 | USD 12.90 | USD 21,040 | SEC 申报 ↗ |
| 2026-03-05 | Herman Jenny | 卖出 (S) | Common Stock | 775 | USD 12.85 | USD 9,959 | SEC 申报 ↗ |
| 2026-03-05 | Farid Ramy | 卖出 (S) | Common Stock | 3,661 | USD 12.91 | USD 47,264 | SEC 申报 ↗ |
| 2026-03-05 | Akinsanya Karen | 卖出 (S) | Common Stock | 1,366 | USD 12.90 | USD 17,621 | SEC 申报 ↗ |
| 2026-03-04 | Abel Robert Lorne | 卖出 (S) | Common Stock | 1,300 | USD 12.81 | USD 16,653 | SEC 申报 ↗ |
| 2026-03-02 | Tran Yvonne | 奖励／授予 (A) | Common Stock | 30,918 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Lorton Kenneth Patrick | 奖励／授予 (A) | Common Stock | 37,812 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Jain Rachit | 奖励／授予 (A) | Common Stock | 17,130 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Herman Jenny | 奖励／授予 (A) | Common Stock | 9,590 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SDGR |
| CIK | 0001490978 |
| 行业 | Healthcare |
| 细分行业 | Health Information Services Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 918 transaction lines from 2020-02-10 to 2026-09-17 3 P purchase lines · 713 S sale lines · 202 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.